Market Overview

Why Atossa Therapeutics Stock Is Trading Higher Today


Atossa Therapeutics (NASDAQ: ATOS) shares are trading higher on Wednesday.

The company announced "successful" in vitro testing results of AT-H201, which is Atossa's proprietary COVID-19 drug candidate.

Atossa  is a clinical stage pharmaceutical company operating in the U.S. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

The clinical-stage programs of the company includes delivery of therapeutics through microcatheters which delivers a number of therapeutics to the ducts in the breast, the site of the majority of early breast cancers and fulvestrant.

Atossa’s stock traded up 28% to $2.24 per share at time of publication on Wednesday. The stock has a 52-week high of $3.25 and a 52-week low of 76 cents.


Related Articles (ATOS)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at